- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02417155
Increasing Plasma Adrenaline Levels Through Breathing Techniques - an Explorative Study (INADRI)
November 9, 2015 updated by: Radboud University Medical Center
Inflammatory cytokines play a pivotal role in rheumatoid arthritis (RA) and innovative non-pharmacological therapies aimed at limiting cytokine production are highly warranted.
Adrenaline, a neurotransmitter of the autonomic sympathetic nervous system, attenuates cytokine production.
Along these lines, endogenous modulation of sympathetic activity could limit inflammation and therefore represent a treatment modality that would empower RA patients to exert self-control over disease activity.
However, both the autonomic nervous system and the inflammatory response are regarded as systems that cannot be voluntarily influenced.
Nevertheless, results from two recent studies demonstrate that this is possible through techniques developed by 'iceman' Wim Hof, namely meditation, exposure to cold, and breathing exercises.
Hof himself and healthy volunteers trained by him were able to voluntarily activate the sympathetic nervous system, resulting in adrenaline release and subsequent suppression of the inflammatory response during experimental human endotoxemia (a model of systemic inflammation elicited by administration of lipopolysaccharide [LPS] in healthy volunteers).
Interestingly, while having been taught all three techniques, during the endotoxemia experiment the trained subjects (like Hof himself) predominantly practiced the breathing exercises consisting of two different techniques.
A 'hyper/hypoventilation' technique, characterized by cycles of hyperventilation followed by breath retention and a 'strength ventilation' technique consisting of deep inhalations and exhalations followed by breath holding.
These techniques resulted in intermittent hypoxia and cyclic shifts in acid-base balance.
Based on these observations and previous studies, the investigators hypothesize that these breathing techniques account for the increased production of adrenaline and thus for the suppressed inflammatory response but it is unclear which of these two techniques is most important.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The main objective of the study is to compare the increase in plasma adrenaline levels during the two different breathing techniques in a group of healthy volunteers trained by Hof.
Also, the investigators investigate whether it is necessary to be trained by Hof and if a relatively short instruction instead of the extensive training is sufficient.
Additionally, the investigators want to evaluate the influence of the training and breathing techniques on pain thresholds.
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Gelderland
-
Nijmegen, Gelderland, Netherlands, 6500 HB
- Intensive Care Medicine, Radboud University Nijmegen Medical Centre
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 35 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Age ≥18 and ≤35 yrs
- Male
- Healthy
Exclusion Criteria:
- Experience with the methods of Wim Hof or other breathing techniques
- Use of any medication
- Smoking
- Use of recreational drugs within 21 days prior to the experiment day
- Use of caffeine or alcohol within 1 day prior to the experimental day.
- Surgery or trauma with significant blood loss or blood donation within 3 months prior to the experimental day.
- Participation in another clinical trial within 3 months prior to the experimental day.
- History, signs, or symptoms of cardiovascular disease
- History of atrial or ventricular arrhythmia
- Hypertension (RR systolic >160 or RR diastolic >90)
- Hypotension (RR systolic <100 or RR diastolic <50)
- Conduction abnormalities on the ECG consisting of a 1st degree atrioventricular block or a complex bundle branch block
- History of asthma, or any other pulmonary disease
- C reactive protein (CRP) > 20 mg/L, White blood count (WBC) > 12x109/L, or clinically significant acute illness, including infections, within 4 weeks before the experimental day.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: HTR
The 'Hoftraining' group (HTR): a group of subjects (n=10) that will be trained extensively by mr.
Hof and his team in both hyper/hypoventilation and strength ventilation breathing techniques.
Total time training is 8 days.
|
Subjects are asked to hyperventilate for an average of 30 breaths.
Subsequently, the subjects exhaled and hold their breath for approximately 2 minutes ("retention phase").
The duration of breath retention will be entirely at the discretion of the subject himself.
Breath retention is followed by a deep inhalation breath, that will be held for 10 s.
Subsequently a new cycle of hyper/hypoventilation begins.
This exercise consists of deep inhalations and exhalations in which every inhalation and exhalation is followed by breath holding for 10 s, during which the subject tightens all his body muscles.
|
|
Active Comparator: EIN
The 'extensive instruction' group (EIN): a group of subjects (n=10) that will receive an extensive instruction course supervised by the research team (in absence of Mr. Hof) in both hyper/hypoventilation and strength ventilation breathing techniques.
|
Subjects are asked to hyperventilate for an average of 30 breaths.
Subsequently, the subjects exhaled and hold their breath for approximately 2 minutes ("retention phase").
The duration of breath retention will be entirely at the discretion of the subject himself.
Breath retention is followed by a deep inhalation breath, that will be held for 10 s.
Subsequently a new cycle of hyper/hypoventilation begins.
This exercise consists of deep inhalations and exhalations in which every inhalation and exhalation is followed by breath holding for 10 s, during which the subject tightens all his body muscles.
|
|
Active Comparator: STR
The 'short training' group (STR): a group of subjects (n=10) that will receive only a short training of 1 hour (immediately prior to the study) by Mr. Hof and his team in both hyper/hypoventilation and strength ventilation breathing techniques.
|
Subjects are asked to hyperventilate for an average of 30 breaths.
Subsequently, the subjects exhaled and hold their breath for approximately 2 minutes ("retention phase").
The duration of breath retention will be entirely at the discretion of the subject himself.
Breath retention is followed by a deep inhalation breath, that will be held for 10 s.
Subsequently a new cycle of hyper/hypoventilation begins.
This exercise consists of deep inhalations and exhalations in which every inhalation and exhalation is followed by breath holding for 10 s, during which the subject tightens all his body muscles.
|
|
Active Comparator: SIN
The 'short instruction' group (SIN): a group of subjects (n=10) that will receive no training, but only an short instruction course of 1 hour (immediately prior to the study) supervised by the research team (in absence of Mr. Hof) in both hyper/hypoventilation and strength ventilation breathing techniques.
|
Subjects are asked to hyperventilate for an average of 30 breaths.
Subsequently, the subjects exhaled and hold their breath for approximately 2 minutes ("retention phase").
The duration of breath retention will be entirely at the discretion of the subject himself.
Breath retention is followed by a deep inhalation breath, that will be held for 10 s.
Subsequently a new cycle of hyper/hypoventilation begins.
This exercise consists of deep inhalations and exhalations in which every inhalation and exhalation is followed by breath holding for 10 s, during which the subject tightens all his body muscles.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Concentration of plasma adrenaline within arm 1
Time Frame: 1 day
|
Our primary endpoint is the difference between plasma adrenaline levels during the hyper/hypoventilation technique and the strength ventilation technique within the HTR group.
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Concentration of plasma adrenaline within arms 2, 3, 4
Time Frame: 1 day
|
Blood will be collected into chilled lithium-heparin tubes and will immediately be placed on ice and centrifuged at 2.000 x g for 10 min at 4 degrees celsius after which plasma will be stored at -80 degrees celsius until analysis.
Plasma adrenaline is measured using High Performance Liquid Chromatography (HPLC) with fluorometric detection.
The investigators will compare levels during the hyper/hypoventilation technique and plasma adrenaline levels during the strength ventilation technique within the EIN, STR and SIN groups.
|
1 day
|
|
concentration of plasma adrenaline between arms 1, 2, 3, 4
Time Frame: 1 day
|
Blood will be collected into chilled lithium-heparin tubes and will immediately be placed on ice and centrifuged at 2.000 x g for 10 min at 4 degrees celsius after which plasma will be stored at -80 degrees celsius until analysis.
Plasma adrenaline is measured using HPLCy with fluorometric detection.
The investigators will compare differences in plasma adrenaline levels during hyper/hypoventilation or strength ventilation between HTR, EIN, STR and SIN groups.
|
1 day
|
|
Plasma interleukine 10 concentration
Time Frame: 1 day
|
EDTA (ethylenediaminetetraacetic acid) anticoagulated blood will centrifuged immediately at 2.000 x g for 10 min at 4 degrees calcium after which plasma will be stored at -80 degrees until analysis.
Concentration of [cytokine] will be measured using a simultaneous Luminex assay according to the manufacturer's instructions (Milliplex; Millipore).
The investigators will compare differences between hyper/hypoventilation and strength ventilation within HTR, EIN, STR and SIN groups as well as differences during hyper/hypoventilation or strength ventilation between HTR, EIN, and SIN groups.
|
1 day
|
|
Body temperature
Time Frame: 1 day
|
Body temperature will be measured using an infrared tympanic thermometer (FirstTemp Genius 2; Sherwood Medical).
The investigators will compare differences between hyper/hypoventilation and strength ventilation within HTR, EIN, STR and SIN groups as well as differences during hyper/hypoventilation or strength ventilation between HTR, EIN, and SIN groups.
|
1 day
|
|
Heart rate, blood pressure
Time Frame: 1 day
|
Heart rate will be recorded with a three-lead electrocardiogram on a Philips MP50 patient monitor.
The investigators will compare differences between hyper/hypoventilation and strength ventilation within HTR, EIN, STR and SIN groups as well as differences during hyper/hypoventilation or strength ventilation between HTR, EIN, and SIN groups.
|
1 day
|
|
Blood pressure
Time Frame: 1 day
|
Blood pressure will be measured on a Philips MP50 patient monitor through a 20-gauge arterial catheter.
The investigators will compare differences between hyper/hypoventilation and strength ventilation within HTR, EIN, STR and SIN groups as well as differences during hyper/hypoventilation or strength ventilation between HTR, EIN, and SIN groups.
|
1 day
|
|
Leukocyte counts and differentiation
Time Frame: 1 day
|
Analysis of leukocyte counts and differentiation will be performed in EDTA anticoagulated blood using routine analysis methods also used for patient samples (flow cytometric analysis on a Sysmex XE-5000).
The investigators will compare differences between hyper/hypoventilation and strength ventilation within HTR, EIN, STR and SIN groups as well as differences during hyper/hypoventilation or strength ventilation between HTR, EIN, and SIN groups.
|
1 day
|
|
Cortisol (plasma)
Time Frame: 1 day
|
Blood will be collected in serum-separating tubes and allowed to clot at room temperature for a minimum of 30 min.
Subsequently, samples are centrifuged at 2,000 × g for 10 min at 4 °C, after which serum is stored at -80 °C until analysis.
Cortisol levels will be determined using a routine analysis method also used for patient samples (electrochemiluminescent immunoassay on a Modular Analytics E170 (Roche Diagnostics).
The investigators will compare differences between hyper/hypoventilation and strength ventilation within HTR, EIN, STR and SIN groups as well as differences during hyper/hypoventilation or strength ventilation between HTR, EIN, and SIN groups.
|
1 day
|
|
Noradrenaline
Time Frame: 1 day
|
Blood will be collected into chilled lithium-heparin tubes and will immediately be placed on ice and centrifuged at 2.000 x g for 10 min at 4 degrees celsius after which plasma will be stored at -80 degrees celsius until analysis.
Plasma noradrenaline is measured using HPLCy with fluorometric detection.
The investigators will compare differences between hyper/hypoventilation and strength ventilation within HTR, EIN, STR and SIN groups as well as differences during hyper/hypoventilation or strength ventilation between HTR, EIN, and SIN groups.
|
1 day
|
|
Blood gas parameters
Time Frame: 1 day
|
Blood gas parameters are analyzed in lithium heparin anticoagulated arterial blood using CG4+ cartridges and a point-of-care i-STAT blood gas analyzer (Abbott).
The investigators will compare differences between hyper/hypoventilation and strength ventilation within HTR, EIN, STR and SIN groups as well as differences during hyper/hypoventilation or strength ventilation between HTR, EIN, and SIN groups.
|
1 day
|
|
Pain threshold
Time Frame: 1 day
|
Pain thresholds before start training/instruction, during each of the breathing techniques, and at the end of the experimental day, objectified with Quantitive Sensory Testing by a dedicated, trained member of the studyteam.
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Kox M, van Eijk LT, Zwaag J, van den Wildenberg J, Sweep FC, van der Hoeven JG, Pickkers P. Voluntary activation of the sympathetic nervous system and attenuation of the innate immune response in humans. Proc Natl Acad Sci U S A. 2014 May 20;111(20):7379-84. doi: 10.1073/pnas.1322174111. Epub 2014 May 5.
- Kox M, Stoffels M, Smeekens SP, van Alfen N, Gomes M, Eijsvogels TM, Hopman MT, van der Hoeven JG, Netea MG, Pickkers P. The influence of concentration/meditation on autonomic nervous system activity and the innate immune response: a case study. Psychosom Med. 2012 Jun;74(5):489-94. doi: 10.1097/PSY.0b013e3182583c6d.
- Zwaag J, Naaktgeboren R, van Herwaarden AE, Pickkers P, Kox M. The Effects of Cold Exposure Training and a Breathing Exercise on the Inflammatory Response in Humans: A Pilot Study. Psychosom Med. 2022 May 1;84(4):457-467. doi: 10.1097/PSY.0000000000001065. Epub 2022 Feb 23.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2014
Primary Completion (Actual)
July 1, 2015
Study Completion (Actual)
October 1, 2015
Study Registration Dates
First Submitted
December 2, 2014
First Submitted That Met QC Criteria
April 10, 2015
First Posted (Estimate)
April 15, 2015
Study Record Updates
Last Update Posted (Estimate)
November 10, 2015
Last Update Submitted That Met QC Criteria
November 9, 2015
Last Verified
November 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- INADRI
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autoimmune Diseases
-
SanofiCompletedHealthy Volunteers | Autoimmune DisorderUnited States
-
argenxNot yet recruiting
-
Changchun GeneScience Pharmaceutical Co., Ltd.RecruitingAutoimmune DiseaseChina
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingAutoimmune EncephalitisItaly
-
University of Sao Paulo General HospitalInsituto Adolfo LutzRecruitingAutoimmune Rheumatologic DiseaseBrazil
-
National Institute of Allergy and Infectious Diseases...RecruitingAutoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy EnteritisUnited States
-
University Hospital, ToulouseRecruitingAutoimmune Encephalitis (AE)France
-
Sehit Prof. Dr. Ilhan Varank Sancaktepe Training...Not yet recruiting
-
Hannover Medical SchoolTechnische Universität DresdenActive, not recruitingAutoimmune HepatitisGermany
-
National Eye Institute (NEI)Completed
Clinical Trials on Hyper/hypoventilation
-
Istanbul UniversityIstanbul University - Cerrahpasa (IUC)Not yet recruitingRespiration Disorders | Obesity | Sarcopenia | Hypoventilation | Sarcopenic Obesity | Obesity Hypoventilation Syndrome (OHS) | Sleep Disorder; Breathing-RelatedTurkey
-
Université Libre de BruxellesWithdrawnCognitive DysfunctionBelgium
-
Peking University Cancer Hospital & InstituteRecruiting
-
Pharos University in AlexandriaNot yet recruitingChronic Kidney Disease (CKD), Stages 3-4 Exercise Tolerance / Functional Capacity Vascular Health / Arterial Stiffness Fatigue in CKD
-
Eye-yon MedicalCompletedCorneal EdemaIsrael
-
Gustave Roussy, Cancer Campus, Grand ParisUnknownEpithelial Ovarian Carcinoma | Figo Stage IIICFrance
-
University of CambridgeUniversity of ManchesterNot yet recruitingEndoscopyUnited Kingdom
-
Rigshospitalet, DenmarkActive, not recruitingSubarachnoid Hemorrhage, AneurysmalDenmark
-
Swissmed HospitalMedical University of GdanskCompleted
-
InnoRa GmbHTerminatedLesions in the Superficial Femoral Artery and/or Popliteal Artery Pars I/IIGermany